ACTILYSE TREATMENT-SET 50 mg/vial
Product details
Registration number: SIN02340P
Classification: Prescription Only
Active ingredients: RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN ACTIVATOR
Strength: 50 mg/vial
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Registrant: BOEHRINGER INGELHEIM SINGAPORE PTE. LTD.
ATC code: B01AD02
HSA approval date: 3 October 1988
Manufacturer(s): BOEHRINGER INGELHEIM PHARMA GMBH & CO KG
Manufacturing country/countries: GERMANY
What are the HSA registration number and classification for ACTILYSE TREATMENT-SET 50 mg/vial?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN02340P
Classification: Prescription Only
What active ingredients and strength are recorded for ACTILYSE TREATMENT-SET 50 mg/vial?
According to the HSA dataset updated 7 August 2026:
Active ingredients: RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN ACTIVATOR
Strength: 50 mg/vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for ACTILYSE TREATMENT-SET 50 mg/vial?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Who is the recorded registrant for ACTILYSE TREATMENT-SET 50 mg/vial?
According to the HSA dataset updated 7 August 2026:
Registrant: BOEHRINGER INGELHEIM SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for ACTILYSE TREATMENT-SET 50 mg/vial?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): BOEHRINGER INGELHEIM PHARMA GMBH & CO KG
Manufacturing country/countries: GERMANY
Where can I look up ACTILYSE TREATMENT-SET 50 mg/vial in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN02340P or the exact product name ACTILYSE TREATMENT-SET 50 mg/vial. The general register link does not preselect this product.
What are the source dates for this ACTILYSE TREATMENT-SET 50 mg/vial record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this ACTILYSE TREATMENT-SET 50 mg/vial record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN02340P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)